OrthoPediatrics’ (KIDS) “Buy” Rating Reiterated at Needham & Company LLC

Needham & Company LLC reiterated their buy rating on shares of OrthoPediatrics (NASDAQ:KIDS) in a report published on Wednesday,Benzinga reports. The firm currently has a $42.00 price target on the stock.

Separately, Truist Financial lowered their target price on shares of OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating on the stock in a research report on Wednesday, December 18th.

OrthoPediatrics Stock Performance

Shares of OrthoPediatrics stock opened at $25.35 on Wednesday. The firm has a market capitalization of $613.88 million, a P/E ratio of -20.61 and a beta of 1.14. OrthoPediatrics has a 52 week low of $21.02 and a 52 week high of $35.99. The company has a quick ratio of 3.68, a current ratio of 7.17 and a debt-to-equity ratio of 0.19. The firm’s 50 day moving average is $24.48 and its two-hundred day moving average is $25.93.

OrthoPediatrics (NASDAQ:KIDS) last announced its quarterly earnings results on Tuesday, March 4th. The company reported ($0.29) EPS for the quarter, beating the consensus estimate of ($0.33) by $0.04. The company had revenue of $52.67 million for the quarter, compared to analyst estimates of $51.16 million. OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.78%. During the same period in the prior year, the firm posted ($0.23) earnings per share. Research analysts forecast that OrthoPediatrics will post -0.93 EPS for the current fiscal year.

Hedge Funds Weigh In On OrthoPediatrics

A number of hedge funds have recently modified their holdings of KIDS. Millennium Management LLC purchased a new position in shares of OrthoPediatrics during the fourth quarter worth approximately $9,798,000. Point72 Asset Management L.P. purchased a new position in shares of OrthoPediatrics during the fourth quarter worth approximately $7,450,000. Wasatch Advisors LP grew its position in shares of OrthoPediatrics by 47.2% during the fourth quarter. Wasatch Advisors LP now owns 696,318 shares of the company’s stock worth $16,141,000 after acquiring an additional 223,217 shares during the last quarter. Wellington Management Group LLP lifted its holdings in shares of OrthoPediatrics by 20.2% during the fourth quarter. Wellington Management Group LLP now owns 1,061,299 shares of the company’s stock worth $24,601,000 after purchasing an additional 178,078 shares during the period. Finally, Dimensional Fund Advisors LP lifted its holdings in shares of OrthoPediatrics by 29.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 671,968 shares of the company’s stock worth $15,576,000 after purchasing an additional 152,681 shares during the period. 69.05% of the stock is currently owned by hedge funds and other institutional investors.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.